Nonetheless, the NY-ESO-1-specific subpopulation represented only 6.6% of all tumor-infiltrating CD8+ T cells in this subject, indicating there are likely many other antigens recognized by infiltrating T cells. The gene discussed is CD8A; the disease is neoplasm.